Jørn Carlsen R.
- Country
- Denmark
- Department
- Department of Cardiology
Research Overview
Data & Insights
Has run more than one trial at 43 of 69 partner sites.
Specializations
Primary Research Focus
The investigator specializes in pulmonary arterial hypertension (PAH) treatment and management, with particular emphasis on evaluating novel therapeutic approaches.
- Advanced PAH Therapeutics
- Long-term Treatment Outcomes
- Disease Progression Management
Their work encompasses both newly diagnosed and ongoing PAH cases, focusing on intermediate to high-risk patient populations.
Therapeutic Innovations
The investigator explores multiple innovative treatment modalities for PAH, including oral inhalation therapies and novel pharmaceutical compounds.
- Seralutinib Administration
- Sotatercept Applications
- Ralinepag Development
Their research evaluates both immediate therapeutic efficacy and long-term safety profiles of these treatments.
Clinical Outcomes
The investigator focuses on measuring specific therapeutic outcomes in PAH treatment, particularly examining:
- Exercise Capacity Assessment
- Clinical Worsening Prevention
- Background Therapy Integration
Their work encompasses comprehensive evaluation of treatment effects in combination with existing PAH therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.